[Gene therapy--hopes and fears].

Area of Science:

• Biotechnology
• Molecular Biology
• Genetics

Context:

• Gene therapy involves delivering correct DNA to target cells for genetic defect correction.
• Two main types exist: somatic and germinal gene therapy.
• As of July 1998, 351 somatic therapy protocols were approved, primarily for cancer and monogenic diseases.

Purpose:

• To review the status and potential of gene therapy, distinguishing between somatic and germinal approaches.
• To highlight the current limitations and future prospects of gene therapy applications.
• To address the safety and ethical considerations surrounding germline gene modification.

Summary:

• Somatic gene therapy focuses on treating existing conditions like cancer and inherited disorders.
• Germline gene modification is proposed for diseases such as retinoblastoma and Tay-Sachs, but faces regulatory and ethical hurdles.
• Significant advancements are needed in controlling gene expression and ensuring the safety of germline modifications.

Impact:

• Gene therapy holds immense potential for treating genetic diseases and cancer.
• Further research into safety and ethical implications is crucial for clinical advancement.
• Controlling gene expression is key to unlocking the full therapeutic potential of gene therapy.